{"pmid":32275258,"title":"Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19.","text":["Exploring the genetics, ecology of SARS-COV-2 and climatic factors as possible control strategies against COVID-19.","The world has been thrown into pandemonium due to the recent Coronavirus Disease 19 (COVID-19) pandemic. Early available clinical data have indicated that geriatric persons cum those with co-morbidity such as cardiovascular, metabolic and immunological disorders suffered severe form of COVID-19. All countries and territories of the world are currently exploring available strategies to control the pandemic with the hope to significantly minimize its morbidity and mortality rate. This present study critically reviewed available and latest research progress on the genetics and ecology of SARS-CoV-2, as well as the influence of climatic factors on the spread of COVID-19, and thus, discussed how these concepts could be harnessed for COVID-19 control and further scientific advancements in resolving the pandemic.","Infez Med","Abdullahi, Idris Nasir","Emeribe, Anthony Uchenna","Mustapha, Jelili Olaide","Fasogbon, Samuel Ayobami","Ofor, Igr Bassey","Opeyemi, Imodoye Sikiru","Obi-George, Chibueze","Sunday, Animasaun Olawale","Nwofe, Justin","32275258"],"abstract":["The world has been thrown into pandemonium due to the recent Coronavirus Disease 19 (COVID-19) pandemic. Early available clinical data have indicated that geriatric persons cum those with co-morbidity such as cardiovascular, metabolic and immunological disorders suffered severe form of COVID-19. All countries and territories of the world are currently exploring available strategies to control the pandemic with the hope to significantly minimize its morbidity and mortality rate. This present study critically reviewed available and latest research progress on the genetics and ecology of SARS-CoV-2, as well as the influence of climatic factors on the spread of COVID-19, and thus, discussed how these concepts could be harnessed for COVID-19 control and further scientific advancements in resolving the pandemic."],"journal":"Infez Med","authors":["Abdullahi, Idris Nasir","Emeribe, Anthony Uchenna","Mustapha, Jelili Olaide","Fasogbon, Samuel Ayobami","Ofor, Igr Bassey","Opeyemi, Imodoye Sikiru","Obi-George, Chibueze","Sunday, Animasaun Olawale","Nwofe, Justin"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275258","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Prevention","Mechanism","Transmission"],"weight":1,"_version_":1663712077847461888,"score":7.9164424,"similar":[{"pmid":32275259,"title":"Exploring the genetics, ecology of SARS-CoV-2 and climatic factors as possible control strategies against COVID-19.","text":["Exploring the genetics, ecology of SARS-CoV-2 and climatic factors as possible control strategies against COVID-19.","The world has been thrown into pandemonium due to the recent Coronavirus Disease-19 (COVID-19) pandemic. Early available clinical data have indicated that geriatric persons cum those with co-morbidity such as cardiovascular, metabolic and immunological disorders suffered severe form of COVID-19. All countries and territories of the world are currently exploring available strategies to control the pandemic with the hope to significantly minimize its morbidity and mortality rate. This present study critically reviewed available and latest research progress of the genetics and ecology of SARS-CoV-2, as well as the influence of climatic factors on the spread of COVID-19, and thus, discussed how these concepts could be harnessed for COVID-19 control and further scientific advancements in resolving the pandemic.","Infez Med","Rabaan, Ali A","Al-Ahmed, Shamsah H","Haque, Shafiul","Sah, Ranjit","Tiwari, Ruchi","Malik, Yashpal Singh","Dhama, Kuldeep","Yatoo, M Iqbal","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J","32275259"],"abstract":["The world has been thrown into pandemonium due to the recent Coronavirus Disease-19 (COVID-19) pandemic. Early available clinical data have indicated that geriatric persons cum those with co-morbidity such as cardiovascular, metabolic and immunological disorders suffered severe form of COVID-19. All countries and territories of the world are currently exploring available strategies to control the pandemic with the hope to significantly minimize its morbidity and mortality rate. This present study critically reviewed available and latest research progress of the genetics and ecology of SARS-CoV-2, as well as the influence of climatic factors on the spread of COVID-19, and thus, discussed how these concepts could be harnessed for COVID-19 control and further scientific advancements in resolving the pandemic."],"journal":"Infez Med","authors":["Rabaan, Ali A","Al-Ahmed, Shamsah H","Haque, Shafiul","Sah, Ranjit","Tiwari, Ruchi","Malik, Yashpal Singh","Dhama, Kuldeep","Yatoo, M Iqbal","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275259","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Transmission","Prevention","Mechanism"],"weight":1,"_version_":1663712077848510464,"score":1183.6051},{"pmid":32221057,"title":"Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.","text":["Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.","A severe form of respiratory disease - COVID-19, caused by SARS-CoV-2 infection, has evolved into a pandemic resulting in significant morbidity and mortality. The unabated spread of the disease is due to lack of vaccine and effective therapeutic agents against this novel virus. Hence, the situation demands an immediate need to explore all the plausible therapeutic and prophylactic strategies that can be made available to stem the spread of the disease. Towards this effort, the current review outlines the key aspects of the pathobiology associated with the morbidity and mortality in COVID-19 patients, which includes a viral response phase and an exaggerated host response phase. The review also summarizes therapeutic agents that are currently being explored along with those with potential for consideration. The broad groups of therapeutic agents discussed include those that: (i) block viral entry to host cells, (ii) block viral replication and survival in host cells, and (iii) dampen exaggerated host immune response. The various kinds of pharmaceutical prophylactic options that may be followed to prevent COVID-19 have also been discussed.","Indian J Ophthalmol","Shetty, Rohit","Ghosh, Arkasubhra","Honavar, Santosh G","Khamar, Pooja","Sethu, Swaminathan","32221057"],"abstract":["A severe form of respiratory disease - COVID-19, caused by SARS-CoV-2 infection, has evolved into a pandemic resulting in significant morbidity and mortality. The unabated spread of the disease is due to lack of vaccine and effective therapeutic agents against this novel virus. Hence, the situation demands an immediate need to explore all the plausible therapeutic and prophylactic strategies that can be made available to stem the spread of the disease. Towards this effort, the current review outlines the key aspects of the pathobiology associated with the morbidity and mortality in COVID-19 patients, which includes a viral response phase and an exaggerated host response phase. The review also summarizes therapeutic agents that are currently being explored along with those with potential for consideration. The broad groups of therapeutic agents discussed include those that: (i) block viral entry to host cells, (ii) block viral replication and survival in host cells, and (iii) dampen exaggerated host immune response. The various kinds of pharmaceutical prophylactic options that may be followed to prevent COVID-19 have also been discussed."],"journal":"Indian J Ophthalmol","authors":["Shetty, Rohit","Ghosh, Arkasubhra","Honavar, Santosh G","Khamar, Pooja","Sethu, Swaminathan"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221057","week":"202014|Mar 30 - Apr 05","doi":"10.4103/ijo.IJO_639_20","keywords":["COVID-19","SARS-CoV-2","prophylaxis","therapy"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352135173013505,"score":171.2861},{"pmid":32230900,"title":"Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","text":["Virology, Epidemiology, Pathogenesis, and Control of COVID-19.","The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.","Viruses","Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai","32230900"],"abstract":["The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review."],"journal":"Viruses","authors":["Jin, Yuefei","Yang, Haiyan","Ji, Wangquan","Wu, Weidong","Chen, Shuaiyin","Zhang, Weiguo","Duan, Guangcai"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32230900","week":"202014|Mar 30 - Apr 05","doi":"10.3390/v12040372","keywords":["*COVID-19","*SARS-CoV-2","*epidemiology","*pathogenesis","*therapeutics"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Transmission","Treatment"],"weight":1,"_version_":1663352135337639936,"score":165.0622},{"pmid":32191830,"title":"COVID-19 - what should anaethesiologists and intensivists know about it?","text":["COVID-19 - what should anaethesiologists and intensivists know about it?","Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.","Anaesthesiol Intensive Ther","Wujtewicz, Magdalena","Dylczyk-Sommer, Anna","Aszkielowicz, Aleksander","Zdanowski, Szymon","Piwowarczyk, Sebastian","Owczuk, Radoslaw","32191830"],"abstract":["Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus."],"journal":"Anaesthesiol Intensive Ther","authors":["Wujtewicz, Magdalena","Dylczyk-Sommer, Anna","Aszkielowicz, Aleksander","Zdanowski, Szymon","Piwowarczyk, Sebastian","Owczuk, Radoslaw"],"date":"2020-03-20T11:00:00Z","year":2020,"_id":"32191830","week":"202012|Mar 16 - Mar 22","doi":"10.5114/ait.2020.93756","keywords":["* COVID-19","* SARS-CoV-2","* acute respiratory distress syndrome (ARDS)","* acute pneumonia","* infection","*viruses"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352133750095872,"score":150.45255},{"pmid":32210130,"title":"Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2.","text":["Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2.","Over the last two decades, the world experienced three outbreaks of coronaviruses with elevated morbidity rates. Currently, the global community is facing emerging virus SARS-CoV-2 belonging to Betacoronavirus, which appears to be more transmissible but less deadly than SARS-CoV. The current study aimed to track the evolutionary ancestors and different evolutionary strategies that were genetically adapted by SARS-CoV-2. Our whole-genome analysis revealed that SARS-CoV-2 was the descendant of Bat SARS/SARS-like CoVs and bats served as a natural reservoir. SARS-CoV-2 used mutations and recombination as crucial strategies in different genomic regions including the envelop, membrane, nucleocapsid, and spike glycoproteins to become a novel infectious agent. We confirmed that mutations in different genomic regions of SARS-CoV-2 have specific influence on virus reproductive adaptability, allowing for genotype adjustment and adaptations in rapidly changing environments. Moreover, for the first time we identified nine putative recombination patterns in SARS-CoV-2, which encompass spike glycoprotein, RdRp, helicase and ORF3a. Six recombination regions were spotted in the S gene and are undoubtedly important for evolutionary survival, meanwhile this permitted the virus to modify superficial antigenicity to find a way from immune reconnaissance in animals and adapt to a human host. With these combined natural selected strategies, SARS-CoV-2 emerged as a novel virus in human society.","Pathogens","Rehman, Saif Ur","Shafique, Laiba","Ihsan, Awais","Liu, Qingyou","32210130"],"abstract":["Over the last two decades, the world experienced three outbreaks of coronaviruses with elevated morbidity rates. Currently, the global community is facing emerging virus SARS-CoV-2 belonging to Betacoronavirus, which appears to be more transmissible but less deadly than SARS-CoV. The current study aimed to track the evolutionary ancestors and different evolutionary strategies that were genetically adapted by SARS-CoV-2. Our whole-genome analysis revealed that SARS-CoV-2 was the descendant of Bat SARS/SARS-like CoVs and bats served as a natural reservoir. SARS-CoV-2 used mutations and recombination as crucial strategies in different genomic regions including the envelop, membrane, nucleocapsid, and spike glycoproteins to become a novel infectious agent. We confirmed that mutations in different genomic regions of SARS-CoV-2 have specific influence on virus reproductive adaptability, allowing for genotype adjustment and adaptations in rapidly changing environments. Moreover, for the first time we identified nine putative recombination patterns in SARS-CoV-2, which encompass spike glycoprotein, RdRp, helicase and ORF3a. Six recombination regions were spotted in the S gene and are undoubtedly important for evolutionary survival, meanwhile this permitted the virus to modify superficial antigenicity to find a way from immune reconnaissance in animals and adapt to a human host. With these combined natural selected strategies, SARS-CoV-2 emerged as a novel virus in human society."],"journal":"Pathogens","authors":["Rehman, Saif Ur","Shafique, Laiba","Ihsan, Awais","Liu, Qingyou"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32210130","week":"202013|Mar 23 - Mar 29","doi":"10.3390/pathogens9030240","keywords":["SARS-CoV","SARS-CoV-2","evolutionary strategies","genomic structure","mutations","phylogeny","recombination or reassortment"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352134923452416,"score":143.97491}]}